The best sites to inject tirzepatide — and how to rotate them

Step 1, Pick your starting site and understand what each one offers

Tirzepatide is injected subcutaneously, meaning just under the skin into the fatty layer, not into muscle. The Mounjaro KwikPen is designed so that when you press it firmly against the skin, the needle reaches that layer at the correct depth, you do not need to adjust the angle yourself.

The abdomen is the most commonly chosen site because it tends to offer a good amount of subcutaneous tissue and is easy to reach. Avoid the two-inch (five-centimetre) zone directly around the navel, where the skin is thicker and absorption can be less consistent.

The thigh (specifically the front or outer surface) works well for people who find the abdomen uncomfortable, or who prefer to sit down while injecting. It can feel slightly more tender, particularly at lower body-fat levels, but many people find it perfectly straightforward once they have tried it. More detail on injecting into the thigh is worth reading if that is your preferred site.

The upper arm is the trickiest to self-administer because you need a free hand to hold the pen steady. If you choose this site, having someone else inject for you is simpler. It is useful when the abdomen or thigh skin is temporarily irritated or bruised.

The Mounjaro SmPC (the full prescribing information available on the Electronic Medicines Compendium (eMC)) lists all three sites and confirms there is no clinically meaningful difference in how much medicine is absorbed between them, so if you want to read about which injection site tends to suit most people using tirzepatide, comfort and rotation should guide your choice rather than any idea that one site is pharmacologically superior.

Step 2 (Rotate systematically, not randomly

Injecting into exactly the same spot every week causes lipohypertrophy) small, firm lumps of scar-like tissue that form when fat cells are repeatedly disturbed in the same place. Once that tissue develops, absorption becomes unpredictable. Prevention is straightforward: move at least an inch (2.5 cm) from the previous injection point each time.

A simple approach is to divide each site into a mental grid. If you use the abdomen, think of it as four quadrants (upper left, upper right, lower left, lower right) and work around them in sequence. The same logic applies to the thigh. After four weeks you will have touched each quadrant once before cycling back. You can also alternate between body areas entirely: abdomen one week, thigh the next, and so on. Either method works; the important thing is that you are not landing in the same patch of skin twice in a row.

A quick checking habit worth building: before each injection, gently press the area you are about to use. If it feels firmer than the surrounding skin, or is still tender from last week, choose a different spot. That takes about ten seconds and can prevent months of absorption problems.

For a broader look at where the best place to inject tirzepatide is depending on your circumstances, as well as when in the week to administer the dose, our page on the best time to inject tirzepatide covers how to pick and keep a consistent day.

Step 3 (Prepare the site and inject safely

Clean the chosen patch of skin with an alcohol swab and wait for it to dry completely) injecting through wet skin stings more and can introduce residue. Sterile alcohol swabs are inexpensive and worth keeping beside your pen so the habit becomes automatic.

Pinch a small fold of skin gently if you are lean or using the thigh, which helps ensure the needle stays in the subcutaneous layer rather than going too deep into muscle. Release the pinch only after the pen has clicked and you have held it in place for the full count recommended in your patient information leaflet, the exact timing is specified there and in the SmPC, and differs slightly by pen strength, so the leaflet always takes precedence over any general guidance.

After injecting, do not rub the site. Press lightly with a clean fingertip if there is any minor bleeding. Discard the pen safely, a sharps container keeps used pens away from household waste and is required in most UK local-authority collections.

If you notice persistent redness, swelling, itching or a growing lump at any injection site, let your prescriber know at the next review. Minor skin reactions are listed among the known side effects on the NHS tirzepatide medicines page, and most settle with better rotation; occasionally they need clinical attention.

Practical notes on storage and handling before you inject

Tirzepatide must be kept refrigerated between 2°C and 8°C, but injecting a cold pen can be more uncomfortable than necessary. The patient information leaflet specifies how long you may keep the pen at room temperature before use, always follow those exact figures, which are published in your pen's leaflet and on the eMC, rather than any number quoted elsewhere.

Keep the pen cap on until the moment of use, and never freeze it. A pen that has been frozen should not be used. If you are travelling and unsure about storage, speak to your prescriber before the trip. Our page on the Mounjaro injection process covers the full handling steps from fridge to disposal if you want a complete walkthrough.

Tirzepatide is a prescription-only medicine; the injection sites above are those licensed in the UK and described in the SmPC. Your prescriber and the patient information leaflet enclosed with your pen are the final word on technique for your individual circumstances. If you have questions about starting treatment, start a free consultation and a GPhC-registered prescriber will review your case the same day.